Who owns TANDEM DIABETES CARE INC (TNDM)? Elite investor 13F holders

2 tracked elite investors reported holding TANDEM DIABETES CARE INC as of 2026-06-30, including D.E. Shaw, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
D.E. ShawTANDEM DIABETES CARE INCSHARE2026-06-302026-08-14 00:00:0010288482.00 USD681808.000000SharesreduceOriginal filing
Tudor InvestmentTANDEM DIABETES CARE INCSHARE2026-06-302026-08-14 00:00:005473264.00 USD362708.000000SharesaddOriginal filing
Renaissance Technologies LLCTANDEM DIABETES CARE INCSHARE2026-06-302026-08-13 00:00:000.00 USD0.000000SharesexitedOriginal filing
Ancora Advisors / Ancora HoldingsTANDEM DIABETES CARE INCSHARE2026-06-302026-08-14 00:00:000.00 USD0.000000SharesexitedOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown